Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Lotiglipron

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Pfizer · Phase 2 · Terminated · Enrollment 902

NCT05579977

EudraCT 2022-002834-15

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.